Competitive DRUGS Act of 2019

United States116e CongrèsHR-1344House of Representatives
Mis à jour : 25 mars 2019

Résumé

Aucun résumé n’est disponible.

Textes du projet de loi

Versions disponibles
Introduced (House)Consulter le texte officiel

1 version disponible

Tous les dossiers disponibles sont affichés.

Chronologie

  1. Referred to the Committee on Ways and Means, and in addition to the Committees on Energy and Commerce, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    House of Representatives

  2. Referred to the Subcommittee on Health.

    House of Representatives

  3. Referred to the Subcommittee on Health.

    House of Representatives

  4. Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.

    House of Representatives